These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15298512)

  • 1. Continuous tenecteplase infusion combined with peri/postprocedural platelet glycoprotein IIb/IIIa inhibition in peripheral arterial thrombolysis: initial safety and feasibility experience.
    Allie DE; Hebert CJ; Lirtzman MD; Wyatt CH; Keller VA; Khan MH; Khan MA; Fail PS; Stagg SJ; Chaisson GA; Vitrella DA; Allie SD; Allie AA; Mitran EV; Walker CM
    J Endovasc Ther; 2004 Aug; 11(4):427-35. PubMed ID: 15298512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenecteplase in acute lower-leg ischemia: efficacy, dose, and adverse events.
    Hull JE; Hull MK; Urso JA; Park HA
    J Vasc Interv Radiol; 2006 Apr; 17(4):629-36. PubMed ID: 16614145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A safety and feasibility report of combined direct thrombin and GP IIb/IIIa inhibition with bivalirudin and tirofiban in peripheral vascular disease intervention: treating critical limb ischemia like acute coronary syndrome.
    Allie DE; Hebert CJ; Lirtzman MD; Wyatt CH; Keller VA; Khan MH; Khan MA; Fail PS; Vivekananthan K; Allie SE; Mitran EV; Chaisson G; Stagg SJ; Allie AA; McElderry MW; Barker EA; Walker CM
    J Invasive Cardiol; 2005 Aug; 17(8):427-32. PubMed ID: 16079449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter-directed thrombolysis for acute limb ischemia caused by native artery occlusion: an experience of a university hospital.
    Wongwanit C; Hahtapornsawan S; Chinsakchai K; Sermsathanasawadi N; Hongku K; Ruangsetakit C; Mutirangura P
    J Med Assoc Thai; 2013 Jun; 96(6):661-8. PubMed ID: 23951822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study.
    Burkart DJ; Borsa JJ; Anthony JP; Thurlo SR
    J Vasc Interv Radiol; 2003 Jun; 14(6):729-33. PubMed ID: 12817039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model.
    Zhang L; Zhang ZG; Zhang C; Zhang RL; Chopp M
    Stroke; 2004 Dec; 35(12):2890-5. PubMed ID: 15514182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using a peptide inhibitor of the glycoprotein IIb/IIIa platelet receptor: initial experience in patients with acute peripheral arterial occlusions.
    Yoon HC; Miller FJ
    AJR Am J Roentgenol; 2002 Mar; 178(3):617-22. PubMed ID: 11856686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke: preliminary observations.
    Seitz RJ; Hamzavi M; Junghans U; Ringleb PA; Schranz C; Siebler M
    Stroke; 2003 Aug; 34(8):1932-5. PubMed ID: 12829861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
    Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
    Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute basilar artery thrombosis with a combination of systemic alteplase and tirofiban, a nonpeptide platelet glycoprotein IIb/IIIa inhibitor: report of four cases.
    Junghans U; Seitz RJ; Wittsack HJ; Aulich A; Siebler M
    Radiology; 2001 Dec; 221(3):795-801. PubMed ID: 11719681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infusion techniques for peripheral arterial thrombolysis.
    Kessel DO; Berridge DC; Robertson I
    Cochrane Database Syst Rev; 2004; (1):CD000985. PubMed ID: 14973961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial clinical results of tenecteplase (TNK) in catheter-directed thrombolytic therapy.
    Razavi MK; Wong H; Kee ST; Sze DY; Semba CP; Dake MD
    J Endovasc Ther; 2002 Oct; 9(5):593-8. PubMed ID: 12431142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of adjunctive intracoronary thrombolytic therapy during complex percutaneous coronary intervention: initial experience with intracoronary tenecteplase.
    Kelly RV; Crouch E; Krumnacher H; Cohen MG; Stouffer GA
    Catheter Cardiovasc Interv; 2005 Nov; 66(3):327-32. PubMed ID: 16208711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of reperfusion regimens with or without tirofiban in ST-elevation acute myocardial infarction.
    Martínez-Ríos MA; Rosas M; González H; Peña-Duque MA; Martínez-Sánchez C; Gaspar J; García H; Gaxiola E; Delgado L; Carrillo J; Leyva JL; Lupi E;
    Am J Cardiol; 2004 Feb; 93(3):280-7. PubMed ID: 14759375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TROPICS 1: a phase III, randomized, double-blind, placebo-controlled study of tenecteplase for restoration of function in dysfunctional central venous catheters.
    Gabrail N; Sandler E; Charu V; Anas N; Lim E; Blaney M; Ashby M; Gillespie BS; Begelman SM
    J Vasc Interv Radiol; 2010 Dec; 21(12):1852-8. PubMed ID: 21111365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter-directed thrombolytic therapy in peripheral artery occlusions: combining reteplase and abciximab.
    Drescher P; McGuckin J; Rilling WS; Crain MR
    AJR Am J Roentgenol; 2003 May; 180(5):1385-91. PubMed ID: 12704056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of abciximab and tirofiban in patients with peripheral arterial occlusive disease and arterial thrombosis.
    Schweizer J; Kirch W; Koch R; Müller A; Hellner G; Forkmann L
    Angiology; 2003; 54(2):155-61. PubMed ID: 12678189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenecteplase versus streptokinase thrombolytic therapy in patients with mitral prosthetic valve thrombosis.
    Kathirvel D; Justin Paul G; Prathap Kumar G; Palanisamy G; Gnanavelu G; Ravishankar G; Swaminathan N; Venkatesan S
    Indian Heart J; 2018; 70(4):506-510. PubMed ID: 30170645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter intraarterial infusion of rt-PA for acute lower limb ischemia: results and complications.
    Swischuk JL; Fox PF; Young K; Hussain S; Smouse B; Castañeda F; Brady TM
    J Vasc Interv Radiol; 2001 Apr; 12(4):423-30. PubMed ID: 11287527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.